Kassberg Thomas Richard - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 11, 2024, Kassberg Thomas Richard's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Officer (CBO & EVP), and currently has 252,823 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RARE insiders.

Data Source: SEC.
Kassberg Thomas Richard - Insider Non-Derivative Transactions of RARE Common Stock
Kassberg Thomas Richard - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 12, 2024 Sell -- (Common Stock) 11509 49.93 252823
Mar 2, 2024 Sell -- (Common Stock) 1011 53.76 264332
Mar 2, 2024 Acquisition -- (Common Stock) 17800 0 264660
Mar 2, 2024 F -- (Common Stock) 274 53.69 265343
Mar 2, 2024 Acquisition -- (Common Stock) 957 0 265617
Oct 24, 2023 Sell -- (Common Stock) 39878 32.78 246860
Oct 24, 2023 M -- (Common Stock) 39878 6.86 286738
Mar 2, 2023 Acquisition -- (Common Stock) 2663 0 230222
Mar 2, 2023 Disposition -- (Common Stock) 3394 45.65 246860
Mar 2, 2023 Sell -- (Common Stock) 1968 45.27 250254
Mar 2, 2023 Acquisition -- (Common Stock) 22000 0 252222